Vinpocetine treatment in acute ischaemic stroke: A pilot single-blind randomized clinical trial

European Journal of Neurology

Volumn 8, Issue 1, 2001, Pages 81-85

  Feigin, Valery L ^a,b   Doronin, B M ^c   Popova, T F ^c   Gribatcheva, E V ^c   Tchervov, D V ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Controlled trial; Ischaemic stroke; Randomized; Vinpocetine

Indexed keywords

APOVINCAMINE; DEXTRAN; VINPOCETINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEXTRANS; DRUG COMBINATIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEUROPROTECTIVE AGENTS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VINCA ALKALOIDS;

EID: 0035122035     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2001.00181.x     Document Type: Article

References (17)

1. A mouse model of focal cerebral ischemia for screening neuroprotective drug effects
2. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction
3. Vinpocetine in acute ischaemic stroke
4. Vinpocetine is as potent as phenytoin to block voltage-gated Na channels in rat cortical neurons
5. Vinpocetine protects against excitotoxic cell death in primary cultures of rat cerebral cortex
6. Interrater reliability of the NIH stroke scale
7. Effect of vinpocetine on red blood cell deformability in stroke patients
8. Effect of vinpocetine on platelet aggregation in patients with cerebrovascular diseases
9. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: Evidence from release and ligand binding studies
10. Vinpocetine increases the neuroprotective effect of adenosine in vitro
11. Functional evaluation: The Barthel Index
12. A double blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin
13. Cerebral vascular accidents in patients over the age of 60: II. Prognosis
14. Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat
15. Vinpocetine prevents ischemic cell damage in rat hippocampus
16. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders
17. Clinical study to evaluate the efficacy and tolerance of vinpocetine i.v. added to standard therapy in patients suffering from an acute apoplectic insult